Product Information
OXAZEPAM 10 MG CAPSULE is a generic product labeled by TruPharma LLC, priced at $0.6695 per EA under NDC 52817029010. Its NADAC has been published 223 times since Dec 2, 2020.
FDA first approved this application on Aug 10, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Oxazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
TruPharma LLCNDC
52817029010
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA071026FDA Approved
8/10/1987
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 10 MG CAPSULE has been published 223 times since Dec 2, 2020, and over the history we have for it it has declined 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6695 per EA |
|---|---|
| All-time high | $0.9352 (Jan 13, 2021) |
| All-time low | $0.6121 (Jan 22, 2025) |
| Median price | $0.8085 |
| Average price | $0.7853 |
| Largest weekly change | +42.0% (Jul 21, 2021) |
| Weeks tracked | 223 |
| Tracking since | Dec 2, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-15.4%
5Y
-23.7%
All
-28.0%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXAZEPAM 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 10 MG CAPSULE, manufactured by TruPharma LLC, is $0.6695 per EA (NDC 52817029010), effective Mar 5, 2025.
How has the price of OXAZEPAM 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 10 MG CAPSULE has declined 28.0%. It has been tracked across 223 weekly CMS publications since Dec 2, 2020.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 10 MG CAPSULE?
Since Dec 2, 2020, the NADAC for OXAZEPAM 10 MG CAPSULE has ranged from a low of $0.6121 (Jan 22, 2025) to a high of $0.9352 (Jan 13, 2021), with a median of $0.8085 per EA.
Are there cheaper alternatives to OXAZEPAM 10 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXAZEPAM 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OXAZEPAM 10 MG CAPSULE?
OXAZEPAM 10 MG CAPSULE (NDC 52817029010) is labeled by TruPharma LLC, and CMS classifies it as a generic product.